Glioma stem cells: their role in chemoresistance. (Q55462193)

12 July 2018

title

Glioma stem cells: their role in chemoresistance. (English)

1 reference

12 July 2018

author name string

Ryosuke Yamada

series ordinal

1

1 reference

12 July 2018

Ichiro Nakano

series ordinal

2

1 reference

12 July 2018

publication date

5 January 2012

1 reference

12 July 2018

published in

World Neurosurgery

1 reference

12 July 2018

volume

77

1 reference

12 July 2018

issue

2

1 reference

12 July 2018

page(s)

237-240

1 reference

12 July 2018

Inhibitors of cancer cell multidrug resistance mediated by breast cancer resistance protein (BCRP/ABCG2).

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.WNEU.2012.01.004

Glioma stem cells promote radioresistance by preferential activation of the DNA damage response

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.WNEU.2012.01.004

Stem cell-like glioma cells promote tumor angiogenesis through vascular endothelial growth factor

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.WNEU.2012.01.004

PTEN/PI3K/Akt pathway regulates the side population phenotype and ABCG2 activity in glioma tumor stem-like cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.WNEU.2012.01.004

The transcriptional network for mesenchymal transformation of brain tumours.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.WNEU.2012.01.004

HEDGEHOG-GLI1 signaling regulates human glioma growth, cancer stem cell self-renewal, and tumorigenicity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.WNEU.2012.01.004

Glioma tumor stem-like cells promote tumor angiogenesis and vasculogenesis via vascular endothelial growth factor and stromal-derived factor 1.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.WNEU.2012.01.004

Isolation and characterization of tumorigenic, stem-like neural precursors from human glioblastoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.WNEU.2012.01.004

Neural stem/progenitors and glioma stem-like cells have differential sensitivity to chemotherapy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.WNEU.2012.01.004

The hypoxic microenvironment maintains glioblastoma stem cells and promotes reprogramming towards a cancer stem cell phenotype

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.WNEU.2012.01.004

Cancerous stem cells can arise from pediatric brain tumors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.WNEU.2012.01.004

A distinct "side population" of cells with high drug efflux capacity in human tumor cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.WNEU.2012.01.004

A cell initiating human acute myeloid leukaemia after transplantation into SCID mice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.WNEU.2012.01.004

Transcriptional profiles of CD133+ and CD133- glioblastoma-derived cancer stem cell lines suggest different cells of origin

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.WNEU.2012.01.004

Drug resistance of human glioblastoma cells conferred by a tumor-specific mutant epidermal growth factor receptor through modulation of Bcl-XL and caspase-3-like proteases

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.WNEU.2012.01.004

A crucial requirement for Hedgehog signaling in small cell lung cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.WNEU.2012.01.004

Molecular subclasses of high-grade glioma predict prognosis, delineate a pattern of disease progression, and resemble stages in neurogenesis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.WNEU.2012.01.004

Expression of Notch-1 and its ligands, Delta-like-1 and Jagged-1, is critical for glioma cell survival and proliferation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.WNEU.2012.01.004

Phase II trial of gefitinib in recurrent glioblastoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.WNEU.2012.01.004

A small-molecule antagonist of CXCR4 inhibits intracranial growth of primary brain tumors.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.WNEU.2012.01.004

Identification of human brain tumour initiating cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.WNEU.2012.01.004

Inhibition of Sonic hedgehog and Notch pathways enhances sensitivity of CD133(+) glioma stem cells to temozolomide therapy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.WNEU.2012.01.004

Integrated genomic analysis identifies clinically relevant subtypes of glioblastoma characterized by abnormalities in PDGFRA, IDH1, EGFR, and NF1

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.WNEU.2012.01.004

Patterns of progression in malignant glioma following anti-VEGF therapy: perceptions and evidence

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.WNEU.2012.01.004

Bcrp1 gene expression is required for normal numbers of side population stem cells in mice, and confers relative protection to mitoxantrone in hematopoietic cells in vivo

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.WNEU.2012.01.004

10.1016/J.WNEU.2012.01.004

7 January 2021

Identifiers

DOI

1 reference

12 July 2018

1 reference

12 July 2018